Remifentanil but not sufentanil induces cardioprotection in human ischemic heart muscle in vitro

Previous studies on animal models have suggested that δ-opioid receptor (OR) signaling is the primary pathway responsible for opioids' cardioprotective effect. We hypothesize that the μ-OR's activation protect...

Source: BMC Clinical Pharmacology - April 20, 2023 Category: Drugs & Pharmacology Authors: Marcin Kunecki, Tomasz Oleksy, Jan Martyn ów, Michalina Zygmunt, Marek Deja, Tomasz Kargul, Jolanta Biernat, Piotr Podolec, Krzysztof S. Gołba and Wojciech Płazak Tags: Research Source Type: research